Discover how psilocybin, ketamine, and MDMA each support trauma healing and why choosing the right approach matters for your ...

The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...

The company is seeking approval from the US regulator for Vraylar (cariprazine) as an add-on to conventional ... lying in wait for Vraylar in the treatment-resistant depression category will ...

AUSTIN (KXAN)- Experts estimate that treatment-resistant depression (TRD) impacts about 2.8 million Americans annually, and a groundbreaking implantable device may offer new hope. Depression affects ...

A Massachusetts hospital is taking a groundbreaking approach to treating depression and anxiety, aiming to help people get ...

Ketamine-assisted couple therapy enhances emotional openness and cognitive flexibility. Different dosing approaches offer ...

The approval makes Vraylar (cariprazine) the " first and only" dopamine and serotonin partial agonist indicated as an add-on therapy for depression, according to AbbVie, adding to the lengthening ...

Postpartum depression is a kind of depression that affects some new moms. This serious medical condition can occur any time in the first year after giving birth, most often hittin ...

Behavioral therapy may help children ... co-occurring conditions like anxiety or depression. Symptoms of attention deficit hyperactivity disorder (ADHD) can lead to various behaviors that may ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Policy update increases access for millions covered by Evernorth Health ServicesMALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial ...